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ABSTRACT

Huang, Yan. M.S., Purdue University, December 2013. Interaction between Maltose
Binding Protein and Escherichia Coli Maltose Transporter. Major Professor: Amy L.
Davidson (late) and Jue Chen.

The ATP-binding cassette (ABC) transporter superfamily is one of the largest
families of transport proteins. The ABC transporters are responsible for selective
permeability of solute across membranes energized by ATP hydrolysis, which occurs in
all domains of life. Maltose transporter is an ABC importer that mediates
maltose/maltodextrin uptake in bacteria and archaea. It is identified as an essential
virulence factor in pathogenic species of Streptococcis pyogenes and Vibrio cholera (1,
2). Escherichia coli maltose transporter is a well-characterized system with crystal
structures and exclusive biochemical studies available. Knowledge of the E. coli maltose
transport mechanism will lead to a better understanding of maltose transporters in the
other species as well as other classes of ABC importers.
The goal of this study was to characterize the mechanism by which the substrate
binding protein stimulates the transport cycle. To study how MBP initiates the transport
process, MBP was spin-labeled at a single residue of the N-lobe and the mobility
surrounding the labeling site was detected by Electron Paramagnetic Resonance. The
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second periplasmic loop of MalF, P2, was found to bind with MBP N-lobe throughout the
catalytic cycle, suggesting that P2 is involved in the recruitment of MBP, as corroborated
by previous studies. In addition, a lack of mobility change at the interface of the MBP Nlobe and P2 suggested that the 5 Å decrease in the distance between MBP and MalF-P2
upon addition of ATP or maltose from previous crosslink study is likely due to a rotation
between MBP and P2. In comparison, maltose decreased the mobility between MalG P3
and MBP at residue 41, suggesting that P3s’ conformation may be sensitive to maltose
binding.
Among the periplasmic loops of the transmembrane domains, the MalF-P2 loop
shares an extraordinarily large interface with MBP N-lobe. It is possible that P2 has
essential roles other than recruiting MBP. However, this is questioned by the fact that P2
is missing in gram-positive and archaea maltose transporters. To test the functional roles
of this region, P2 was truncated and the maltose transporter mutant without P2 was tested
through in vivo maltose transport assays and then in vitro ATPase activity assay in
nanodiscs. Results demonstrate that the interaction between P2 and MBP is essential to
maltose transport. To further investigate the functions of P2, a P2-truncated mutant of a
binding-protein independent mutant (F500) was constructed. The MacConkey assay
result shows that this mutant can transport maltose in vivo, indicating that P2 is likely to
be involved only in recruiting MBP.
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CHAPTER 1. INTRODUCTION: STRUCTURE, FUNCTION AND DYNAMICS OF
THE MALTOSE TRANSPORTER IN ESCHERICHIA COLI

1.1

ATP-Bing Cassette (ABC) Systems

The ATP-binding cassette (ABC) systems couple the energy of ATP hydrolysis to
import and export molecules, as well as several non-transport-related processes including
translation, elongation and DNA repair (3). Despite the diverse population of substrates
and the difference in the direction of transport, ABC proteins share a common
organization composed of two integral membrane domains and two peripheral ABC
domains (4). The sequence and structure of the nucleotide-binding domain are highlyconserved. ABC transporters play a significant role in both basic membrane biology and
medical applications. In bacteria, ABC transporters are critical for survival; these proteins
are targets for the development of antibacterial vaccines and therapies (5). In humans,
several genetic defects in these proteins play a role in many diseases, such as cystic
fibrosis, hyperinsulinemia, and macular degeneration (4).
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Figure 1.1 Structure of maltose transporter in a catalytic intermediate conformation.
PBID is 3PV0 (6). Subunits are colored as indicated in the figure.

1.2

Structure of the MBP-MalFGK2 Complex in E. coli

E. coli maltose transporter is one of the most extensively-studied among all the
ABC transporter systems. A pictorial representation of this system is given in Figure 1.1.
The transmembrane domain (TMD) contains an intertwined heterodimer of MalF and
MalG. Functional reconstitution of the subunits of E. coli maltose uptake system in vitro,
the MalFGK2 complex, has been demonstrated successfully (7, 8). MalG of the E. coli
maltose transporter is homologous to other species. The N-terminal periplasmic loop of
MalF, the P2 loop, is large (approximately 180 residues), but, interestingly, it is unique to
Enterobacteriaceae (9, 10). Although MalF TM 1 and TM 2 are usually missing in grampositive or archaea maltose transporters, they can be truncated without affecting
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MalFGK2 structure or function (11). However, it is unclear whether truncation of P2 will
affect the function of E. coli maltose transporter. Both MalF and MalG contain three
periplasmic loops interacting with MBP and an EAA loop binding tightly with MalK (6).
MBP is a periplasmic protein in E. coli but is usually a lipoprotein anchored to the
membrane in gram-positive and archaea maltose transporter systems (9, 12).

Figure 1.2 Structure of ATP-bound MalK Subunits (6). Left, the MalK dimer viewed
down the local twofold axis. Right, the ATP-binding site, showing that Walker A and
Walker B from one MalK subunit (green) and LSGGQ from the other MalK subunit (red)
are making contact with one ATP molecule. ATP is represented in the ball-and-stick
model.

Similar to other ABC systems, the N-terminal domain of MalK contains a RecAlike subdomain and a helical subdomain (Figure 1.2). The helical subdomain contains the
LSGGQ motif, which is unique to ABC transporters. Like other bacterial ATP-binding
cassettes MalK also has a C-terminal regulatory domain. This domain contributes
substantially to maintaining two isolated MalK subunits as a dimer even in the absence of
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ATP (13, 14), whereas other isolated cassettes behave as monomers without ATP. In the
crystal structure (6), two ATP molecules are bound along the dimer interface contacting
residues in the Walker A and B motifs of one MalK monomer and the LSGGQ motif of
the other MalK monomer.
The opening and closing motions of the MalK nucleotide-binding interface during
ATP hydrolysis drive maltose across the membrane. Interestingly, these motions are
demonstrated to be coupled to conformational changes of MBP and MalFG during the
translocation cycle (15-18). The rate of maltose transport displays a sigmoidal
dependence on the MBP concentration, with the half maximal uptake rate at about 25 to
100 µM MBP (15, 16). In addition, ATPase activity of the MalFGK2 complex is strongly
inhibited by vanadate; however, the isolated MalK is not (17, 18). The current progress in
studying the coupling of maltose transport and ATP hydrolysis in the catalytic pathway
will be introduced in the next section.

1.3

Alternating Access Mechanism of the Maltose Transporter

Three states of the catalytic cycle have been crystallized (6, 19, 20): (i) resting state,
(ii) pretranslocation (pre-T) state and (iii) transition state (Figure 1.3). In the resting state
(Figure 1.3A-B), MalK dimer interface is open and MalFG is facing inward to the
cytoplasm (17, 21, 22). MalF P2 loop initially interacts with the N-lobe of MBP and
assists MBP docking onto MalG. Upon the binding of maltose, MBP is stabilized in the
closed conformation.
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Figure 1.3 Alternating access mechanism of the maltose transporter (19, 23, 24). (A, B)
Resting state: MalK interface is open, MalFG is facing inward and MBP is stabilized in
the closed conformation after binding maltose. (C) Pre-T state: MalK interface is semiopen, MalFG is in an intermediate conformation between inward- and outward- facing,
and MBP is binding tightly with MalFG. (D) Transition state: MalK interface is closed,
MalFG is facing outward and MBP is open, and maltose is translocated to the binding site
of MalFG. (D-A) After ATP hydrolysis, the MalK dimer interface opens and MalFG is
reoriented to the inward-facing conformation, releasing maltose into the cell. The lower
panel shows slab views of the maltose transporter in resting state (left), pre-T state
(middle) and transition state (right), respectively.
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In the pre-T state (Figure 1.3B-D), the MalK dimer interface is semi-open, MalFG
is in an intermediate conformation between inward- and outward- facing, and maltosebound MBP has a tight binding with MalFG. In the absence of MBP, the resting state
transporter displays little ATPase activity, indicating that there is a high energy barrier in
the progression from inward- to outward-facing conformations that ATP binding alone
cannot overcome (3, 22, 25). An intermediate conformation of MalFGK2 was captured by
the “pre-T” crystal structure. This intermediate conformation is supposed to be of highenergy since the partial closure of the MalK dimer interface can promote to a fully closed
transition state by the addition of Mg ion and the non-hydrolysable ATP analog AMPPNP (19, 25). The detailed mechanism of how the transporter converts from resting state
to pre-T is not yet clear. MBP or nucleotide alone does not trigger the conformational
changes from resting state to transition state (3, 22). The pre-T crystal structure reveals
that MalFGK2 can convert to the pre-T state with maltose and MBP in the absence of
ATP, and can proceed to the transition state by the addition of Mg ion and the
nonhydrolysable ATP analog, AMP-PNP. However, the EPR studies showed no mobility
changes for the four single spin mutations labeled at Q-loop (S83C), or the helical
subdomain (V120C, Q122C, and A124C) of MalK in the intact transporter following the
addition of either maltose-bound MBP or Mg-AMP-PNP alone(22). The EPR data are not
necessarily inconsistent with the crystal structure since it only indicates no binding or
opening at the dimer interface but may not show rotation motions of the MalK dimers. It
is likely that MalK dimers rotate toward a partial closure in the presence of maltosebound MBP without ATP.
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In the transition state (Figure 1.3D), the MalK dimer interface is closed and ATP(s)
is positioned at the catalytic site for hydrolysis. MalFG turns out-ward facing while MBP
is open, allowing maltose to translocate into the low-affinity binding site in MalFG.
Radioactive elution profile of the vanadate trapped complex showed that MBP is tightly
bound with MalFG and that maltose is not bound tightly by MBP in the vanadate-trapped
species. Consistently, the crystal structure of the transition state showed that the open
MBP co-crystallizes with the transporter and maltose locates at the MalFG binding site (6,
19). The crystal structure of MalFGK2 with wild-type MBP converts from the pre-T state
to the transition state when Mg and AMP-PNP are added. In contrast, the pre-T state
MalFGK2 with the crosslinked MBP mutant that is locked in the closed conformation
cannot proceed to the transition state by the addition of Mg ion and AMP-PNP (19).
Therefore, the high affinity of open MBP with MalFGK2 in the vanadate-trapping
transition state indicates that open MBP may play a key role in stabilizing the outward
facing conformation of MalFG (6, 19, 26). Theoretically, unliganded MBP should not
convert the open MalK dimer to closed dimer conformation. However, experimental data
has shown a weak stimulation of unliganded MBP on ATP hydrolysis. This is likely to be
due to a very small population of transporters that engage in high-affinity binding with
the open MBP and progress far enough toward the transition-state conformation (27).
Although a posthydrolysis state of the entire transporter is yet to be crystallized
(Figure 1.3D-A), EPR studies and analysis of the isolated NBD structures suggest that
ADP is not sufficient to stabilize the closed dimer conformation (17, 21, 22). Thus, MalK
dimer interface opens after ATP(s) hydrolysis, and MalFG will be likely to reorient to the
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inward-facing conformation, releasing the substrate from the low-affinity TMD binding
site into the cell through diffusion (Figure 1.3) (28).
The studies on mutations of the transporter comparing the ATPase activities of the
intact transporter and those of the isolated MalK dimers provides more detailed
information on sites possibly involved in the coupling between MalK and MBP. The
stimulatory effect of MBP on the ATPase activity of the intact transporter is prevented by
the mutation of residue Q140 following the LSGGQ motif while the ATPase activity of
isolated MalK is not affected by MBP, suggesting a role of the LSGGQ motif in the
communication between MBP and MalK (21). The P2 (second periplasmic) loop of MalF,
the first periplasmic (P1) loop of MalG and the EAA loop of MalG were reported by
mutation suppressor studies to be involved with the communication between MBP and
MalK (28). Researchers have sought to unveil the mystery of this coupling between
substrate translocation and ATP hydrolysis through isolation and analysis of the binding
protein-independent (BPI) mutants of the maltose transporter, as described in the next
section.

1.4

Binding Protein-Independent (BPI) Mutants

Binding protein-independent (BPI) transporters can transport maltose into the cell
independently of MBP (29, 30). A pictorial presentation of BPI in comparison with wildtype maltose transporter is given in Figure 1.4A. BPI mutants are similar to the wild-type
in terms of maltose-specificity, as well as the affinity, cooperativity, vanadate sensitivity,
and substrate specificity of the ATP binding sites (25, 30, 31). Genetic analysis shows
that BPI requires two mutations. Usually, one is located at the C-terminus of the
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transmembrane helix while the other is located in a periplasmic loop which exposes the
maltose binding site of the transmembrane domain to the periplasm and perturbs the
productive interaction between MBP and the transporter (23).

(A)

(B)

Figure 1.4 A binding protein (BPI) mutant of the maltose transporter. (A) Model for BPI
maltose transport (31). (B) Structure of the maltose transporter (PBD ID: 3PV0) with
sites of the BPI mutation F500 labeled (MalF G338R and N505I). The sphere in red is
G338 at MalF. The sphere in grey is N505 at MalF C-terminus. Color codes: purple,
MBP; yellow, MalF; cyan, MalG; red and green, MalK dimer.

MBP was found to have an effect on the BPI catalytic cycle different from that of
the wild-type transporter. As the concentration of MBP increases, its stimulation on
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maltose transport and ATPase activity of the wild-type maltose transporter keep increase
and then go flat when MBP concentration is saturated. In contrast, higher concentration
of MBP (>1mM) severely inhibits maltose transport of BPI, perhaps because MBP fails
to separate from the BPI, or it shifts MalK to an open rather than a closed conformation
while bound maltose are not delivered to the membrane binding site (32, 33). However,
in some BPI mutants such as MalG511 MalFGK2 transporter, MBP at lower
concentrations still stimulates maltose transport (34). Efforts have been made by
researchers on a better understanding of the mechanism of the BPI mutants in order to
gain us more knowledge on the mechanism of the wild-type transporter.
Different statements about the resting conformation of BPI can potentially explain
the working mechanism of BPI. One explanation is that the transporter rests in an
outward-facing state which exposes the low-affinity transmembrane maltose binding site
to the periplasm (35). This is based on the identical protease susceptibility data of BPI
periplasmic loops of MalF and MalG and of the transition-state maltose transporter
mutant (MalKE159Q) MalF and MalG (35). A more rational explanation is that BPI rests
in a high-energy intermediate state which can easily proceed to the transition state in the
presence of nucleotide (19, 25). Fluorescence data supportive to this explanation showed
that the accessibility of the BPI ATP-binding site is less than that of the wild-type
transporter at resting state and similar to the wild-type transporter in the presence of MBP
and vanadate (36).
Based on these findings, we assume that the double mutations of BPI drives the
majority of the MalK domains to rest in a semi-open conformation that favors proceeding
to closed conformation in the presence of ATP and Mg. MBP is no longer required to
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overcome the energy barrier of a shift from open to semi-open conformation. Maltose can
also enter the MalFG binding site because the site is exposed to the periplasm. F500 is
one of the BPI mutants with mutations of MalF G338R and N505I (Figure 1.4B). F500
was used in this work on the function of P2 by constructing a P2-deleted mutant of F500
as described in Chapter 4.
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CHAPTER 2. EXPERIMENTAL PROCEDURES

2.1

Mutagenesis

The Quikchange II XL site-directed mutagenesis kit (Stratagene) was used to
generate single mutations in the variants of the malE gene encoding MBP with a Cterminal polyhistidine tag (37). We constructed the double mutants of malF by two steps
of single mutation with the PCR machine and PfuUltra II Fusion HS DNA Polymerase
and then digested with DpnI. The sequences of the mutant genes were verified by DNA
sequencing. Dr. Michael Oldham replaced 164 residues (94 to 257) of MalF-P2 in the
maltose transporter by a short linker of GSGSG, and the mutant is named MalF(ΔP2)GK2
(figure 2.1). In vivo function of the mutant proteins was confirmed by complementation
of a chromosomal deletion of malE, malF, malG, malK (strain AD126 (argH his rpsL1
malTc, malB∆13 ∆uncBC ilv::Tn10, F'lacIq Tn5), as judged on 1 % maltose MacConkey
agar (Difco) (38). Plasmid-encoded mutants that are functional yield colonies that turn
red after incubation overnight at 37°C.
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Figure 2.1 Diagram of the secondary structure of MalF (blue) with P2 highlighted in red
square. The amino acid residues 94-257 of MalF-P2 are replaced with GSGSG (6).
2.2

In vivo maltose transport assay: MacConkey assay

MacConkey plates were prepared by autoclaving MacConkey agar and then
supplementing with 1% maltose and antibiotics. E. coli strain AD126 carrying a genomic
deletion of malE, malF and malG, was transformed with plasmids encoding different
combinations of the wild-type or mutant E. coli maltose transporter components. The
cells of the transformed strains were then spread on MacConkey plates. Colonies were
observed after incubations of either 12 hours or 14 hours at 37 °C. Red and white
colonies indicate efficient (positive) and deficient (negative) maltose transport,
respectively.
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2.3
2.3.1

Expression and Purification of Proteins

Expression and Purification and Assembly of MalFGK2 Complex

MalF, MalG and MalK were overexpressed simultaneous with two plasmids in the
strain AD126 (argH his rpsL1 malTc malB∆13 ∆uncBC ilv::Tn10 F'lacIQ Tn5) which
carries the deletion of F0-F1 ATPase. Then the three subunit proteins were overexpressed
and co-purified as a complex (MalFGK2) by affinity chromatography using a 6×histidine
tag attached to the C-terminus of MalK as described previously (6). The modification of
the protocol is that the cell pellet resuspension buffer contains 20 mM Tris (pH 8.0), 5
mM MgCl2, 10% glycerol, and 0.4% n-Dodecyl-β-D-Maltopyranoside (DDM, Anatrace).
Extracted MalFGK2 was purified on cobalt Talon resin (Clontech) in buffer containing 20
mM Tris (pH 8.0), 100 mM NaCl, and 0.015% DDM. The eluted fractions were dialyzed
overnight at 4°C to remove imidazole and then followed by size-exclusion
chromatography (Superdex 200, GE Healthcare). Proteins were concentrated with a
Millipore filter with 100 kDa cut-off and stored in -80°C until ready for use.

2.3.2

Expression, Purification and Spin Labeling of MBP

Wild-type or mutant MBP was cloned into pMCSG7 LIC vector, which encodes a
10xHis tag at the N-terminus of the protein, and then expressed in the E. coli strain
BL21(DE3) Star. Cells were grown in Luria-Bertani medium at 37°C to the
midexponential phase and then the overexpression of MBP was induced by isopropyl-dthiogalactoside at 22°C for 20 hours. MBP was purified by cobalt-affinity
chromatography in buffer containing 20 mM Tris-HCl pH 8.0 and 150 mM NaCl (2mM
DTT was added for the cysteine mutants of MBP) and gel filtration (Superdex 75, GE
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Healthcare) chromatography in buffer containing 10 mM Tris-HCl pH 8.0, 200 mM NaCl.
To spin label the cysteine mutants of MBP (residue 41 and 271), 1 mL of a 200 µM
solution of purified MBP was pretreated with 200 µM DTT to break any nonphysiological MBP dimers formed due to the oxidizing environment of the cobalt affinity
resin, then incubated with 2 mM MTSL and 500 µL nickel-Sepharose 6 Fast Flow resin
(GE Healthcare) overnight with gentle shaking at 4°C. The resin was collected in a
column, washed with a buffer containing 20 mM Tris-HCl at pH 8.0 with 100mM NaCl
and 1mM EDTA to remove excess spin label.

2.3.3

Expression, Purification, and Removal of Histidine-tag of Membrane Scaffold
Protein (MSP)

Expression and purification of a Membrane Scaffold Protein (MSP) for
reconstituting nanodiscs with a diameter of 12.1 nm were performed as described
before(39). In brief, the plasmid (pMSP1E3D1; Addgene) encoding for a polyhistidinetagged MSP with TEV protease cleavage site at the N-terminus was transformed into E.
coli strain BL21(DE3). 50ml of LB medium supplemented with 30 μg/mL kanamycin
was used to grow cells. Till OD600 reached 0.6, the entire culture was transferred into a
500 mL TB medium (plus 30 μg/mL kanamycin) in a 2L flask.

The culture was

incubated at 37 °C, induced by 1mM IPTG isopropyl β-D-1-thiogalactopyranoside (IPTG)
when the OD600 reached 2.5-3.0, and then centrifuged at 4,000 x g for 15 min at 4 °C.
The cell pellet was resuspended in 30 mL of 20 mM sodium phosphate buffer with pH of
7.4 containing 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma), 1% Triton X-100
(Sigma) and 30 mg/L DNAse I (Roche). Then cells were broken by passing the
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resuspension through a high-pressure homogenizer (Emulsiflex-C5; Avestin) at
1500~2000 psi. Cell debris was removed by centrifugation at at 80,000 x g for 40 min at
4 °C. The supernatant was mixed with pre-equilibrated Ni Sepharose 6 Fast Flow resin
(GE Healthcare), for 1 hour with gentle rocking at 4 °C. Then the mixture was loaded
into a column, allowing the liquid to flow through, followed by 1) 10 column volume
(CV) washes of Tris/HCl 40 mM pH 8, NaCl 0.3 M, Triton X-100 1%; 2) 5 CV washes
of Tris/HCl 40 mM at pH 8, 0.3 M NaCl, 50 mM sodium cholate, 20 mM imidazole; and
3) 7 CV washes of 40 mM Tris/HCl at pH 8, 0.3 M NaCl, and 50 mM imidazole. MSP
was eluted with 40 mM Tris-HCl at pH 8.0, 300 mM NaCl, and 400 mM imidazole. To
store the uncut MSP, it was first dialyzed against 3.5 L of buffer A (20 mM Tris/HCl at
pH 8 and 100 mM NaCl) at 4 °C and then frozen in -20°C. To cleave the N-terminus histag, before dialysis, MSP was incubated with TEV in the presence of 5 mM βmercaptoethanol overnight and be passed through cobalt-affinity column to remove TEV
protease and uncleaved MSP.

2.4

Reconstitution of MalFGK2 in Nanodiscs

Nanodiscs represent a more native environment than liposomes, detergent micelles
or bicelles and allow the study of purified membrane proteins with many techniques
including size-exclusion chromatography, electron paramagnetic resonance, and
analytical ultracentrifucation. Nanodiscs are soluble disk-shaped membrane patches.
They contain a phospholipid bilayer encircled by a membrane scaffold protein. The
MalFGK2 was shown to recover its MBP-dependent ATP hydrolysis with little to no
basal activity in both bicelles and nanodiscs (39). While both membrane mimics
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represent alternative reconstitution systems for MalFGK2, reconstitution in nanodiscs is
more convenient than in bicelles and it is suitable for studying the transporter using size
exclusion chromatography and electron paramagnetic resonance spectroscopy.
The nanodiscs were prepared using a certain ratio of soybean phospholipids: MSP:
maltose transporter specified in corresponding sections. Cholate was added to solobilize
the lipids. The final concentration of cholate was 25 mM, which is well above its critical
micelle concentrations. The solubilized lipids, DDM-stabilized MalFGK2 and purified
MSP were mixed in a final volume of 250 μL in a microcentrifuge tube. The final
concentrations of the maltose transporter and glycerol were 6 ~15 μM and < 3%,
respectively. The assembly mixture was allowed to equilibrate for 1 hour at room
temperature with gentle rocking. Then pre-washed biobeads SM-2 (BioRad) were
dehydrated by vacuuming and were incubated with the mixture for 3 hours at room
temperature with gentle rocking to trigger self-assembly of the nanodiscs by detergent
removal. Then the bottom of the microcentrifuge tube was pierced. With a new
microcentrifuge tube collecting the eluate, the microcentrifuge tube containing the
mixture was spun at 1,000 ×g to separate the nanodiscs from the biobeads. Finally, the
sample was spun at 10,000 ×g to remove any precipitates.

2.5

Size Exclusion Chromotography

The procedures of size-exclusion chromatography conducted in section 4.4 are
described in (33). Samples (10 µL) in Buffer A were passed through a pre-equilibriated
Superdex 200 5/150 size exclusion column (GE Healthcare) at room temperature at a
flow rate of 0.1 mL/min using an AKTA purifier chromatography system. The void
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volume was at 1.0 mL. The protein standards (Biorad) were (kDa): 670, 158, 44 and 17,
which gave the following retention volumes (mL): 1.12, 1.56, 1.89 and 2.18, respectively.
The procedures conducted in other sections are described as the following.
MalFGK2 in buffer containing 20 mM Tris (pH 8.0), 100 mM NaCl, and 0.015%
DDM.were passed through a Superdex 200 10/60 size-exclusion column and MBP in
20mM Tris-HCl 150mM NaCl buffer (pH 8) were injected into the Superdex 75 10/60
(for MBP) size-exclusion column (GE Healthcare). The column runs at 4°C at a flow rate
of 1 mL/min using an AKTA purifier chromatography system.

2.6

ATPase Activity Assay

A coupled ATP-regeneration system was used to measure the ATPase of the
maltose transporter complex as described in (3). Briefly, besides the maltose transporter,
the ATPase activity assay solution consists of 50 mM Hepes/KOH at pH 8.0, 10mM
MgCl2, 4 mM phosphoenol pyruvate, 60 μg/ml pyruvate kinase, 32 μg/mL lactate
dehydrogenase, 0.3 mM NADH and 1.5 mM ATP, in presence or absence of 150 μM
maltose or MBP. The concentration of MBP will be specified in the later sections.
Typically, 1 μg maltose transporter in nanodiscs assembly was added to a final volume of
70 μL for the assay. The amount of MalF(ΔP2)GK2 mutant used in the assay is 10 μg. A
5-min preincubation of the sample with ATPase activity assay reagents at room
temperature was employed prior to the addition of ATP. The ATPase activity was
measured

at

room

temperature.

Activity

was

reported

as

μmol

of

ATP

hydrolyzed/min/mg of maltose transporter added to the reconstitution mixture for the
nanodiscs.
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2.7

Electron Paramagnetic Resonance (EPR)

X-band continuous wave (CW) EPR spectroscopy was carried out on a Bruker
EMX-plus fitted with an ER4119HS cavity using WinEPR v4.40 as the computer
interface. Sample volume was 30μl. The spectra were recorded at room temperature using
10 mW microwave power and 100 kHz modulation amplitude over 1.0 Gauss (G). Nine
times over a 100 G scan width will be used. The spectra will be normalized to the same
number of spins, calculated using Bruker WinEPR Processing, as the normalized double
integral of the signal.

2.8

Analytical Ultracentrifugation (AUC)

The sedimentation coefficient, s, is described by the Svedberg equation:

Where ν is the velocity of the molecule, ω2r is the strength of the centrifugal field,
M is the molecular mass, f is the frictional coefficient (which is directly related to
macromolecular shape and size), ρ is the density of the solvent, N is Avogadro’s number,
and

is the partial specific volume of the solute.
In a high-speed sedimentation velocity experiment, the solute moves away from

the air-solvent interface (i.e. the meniscus) to the bottom of the cell and forms a solute
concentration gradient, named the boundary. The boundary sediments and diffuses with
time and displays “boundary spreading” over the course of the experiment. The
combination of the sedimentation and diffusion in the ultracentrifuge cell is described in
terms of the flow, J (40):
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J=sw2rc-D(∂c/∂r)
where D is the diffusion coefficient, c is the solute concentration, and ∂c/∂r is the solute
concentration gradient. In theory, the sedimentation velocity experiments can determine s
and D (which is proportional to f). In the proposed research, M and D of the molecules
are known. Considering two proteins with similar shape and size, the greater the
molecular mass is, the bigger the sedimentation coefficient will be.

In addition,

concentration is positively correlated with UV280 which is detected during spinning.
Given the relation of UV280 absorption versus s, we can quantify the amount of the
nanodiscs of MalFGK2 bound and unbound with MBP and finally plot the binding curve
to obtain the dissociation constant.

2.9

Intrinsic Fluorescence Binding Assay

The binding assay is done in a fluorometer excited at 280nm, emitting at 344nm
(41). The volume of the cuvette is 3mL. It is assumed that both gal-glu4 and MBP have
1:1 binding to MBP. The data are fitted with the equation (42):
f = [L] free / (Kd + [L] free)
where f is the binding fraction,. L is the ligand and Kd is the dissociation constant.
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CHAPTER 3. INITIAL INTERACTION BETWEEN MBP AND MALFG

3.1

Introduction

Usually, ABC transporters share a feature of substrate-bound binding protein
(importers) or substrate (exporters) stimulation of the transporter ATPase activity, thus
avoiding futile cycles of ATP hydrolysis and optimizing substrate transport efficiency. As
an extensively-studied example, maltose transporter can be stimulated by maltose-bound
MBP up to several-thousand fold. However, like other ABC transporters, the mechanism
by which MBP stimulates the maltose transport is unclear.
MBP consists of two lobes, a C-lobe that contacts MalF and an N-lobe that binds
MalG and the MalF-P2 loop (Figure 3.1). Previous EPR studies on C-lobe MBP in our
lab (33, 43) have shown spectral broadening by EPR when maltose was added into the
MalFGK2 nanodiscs and spin-labeled MBP 41C/211C sample, indicating that maltose
triggers MBP closure. However, how MBP first interacts with the transporter and why
MBP stimulates ATP hydrolysis better with maltose than without remains unclear. Our
hypothesis is that maltose enhances the interaction between MBP and maltose transporter.
To test, the three interface regions between MBP and MalFG will be investigated by
conducting EPR experiments with single spin label on MBP mutants.
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Figure 3.1 Three regions of interface between MBP and MalFG. A ribbon diagram (left)
and a slab view (right) of the interacting regions between MBP (magenta) and MalF (blue)
as well as between MBP and MalG (yellow) in the crystal structure (PBD ID: 3PV0). The
interfaces are highlighted in red circles.

3.2

Initial interaction between MBP N-lobe and MalF-P2

To test the interaction between MBP N-lobe and MalF-P2 throughout the catalytic
cycle, a cysteine mutant of MBP (MBP E274C) at the interface of P2 and MBP N-lobe
was prepared for the EPR experiment. The MBP E274C mutant exhibited an in vivo
transport positive phenotype on MacConkey agar with 1% maltose, suggesting that this
mutant is able to uptake maltose. Spin-labeled MBP E274C was concentrated to 60 μM
and stepped through the maltose transport cycle by successively adding 120 μM
MalFGK2 and the ligands as reported before (43). Ficoll alone was added to MBP
mutants to simulate a decrease in the rate of tumbling that MBP would experience
following interaction with the transporter (44).
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(A)

Figure 3.2 Interaction of MTSL-modified MBP E274C with MalFGK2. (A) Location of
MBP E274 in the maltose transporter (PBD ID: 3PV0). Colour codes: magenta, MBP;
yellow, MalF; cyan, MalG; red and green, MalK dimer. MBP E274 is shown in an
enlarged view in darker magenta. (B) The interaction with MalFGK2 and the effect of
maltose ligands. The small picture on the right shows the effect of Ficoll. MBP E274C
was present at 50 μM and MalFGK2 was stabilized in nanodiscs at 100 μM. The buffer
contains no NaCl. EPR spectra are 100G wide. They are color coded according to the
ligands, overlaid and normalized to the same number of spins.

The spectrum of MBP E274C and FicoII is very similar to that of MBP274C alone
(Fig 1B), which indicated that the additional shoulder in the spectrum of MBP274C and
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MalFGK2 stabilized in nanodiscs results from the binding of MBP to MalFGK2 instead of
a change in the rate of molecular tumbling. Subtraction of the unbound MBP from the
composite spectrum allowed us to estimate that 72% of MBP was bound to the
transporter. There was little difference in the height of the immobile shoulder (see arrow)
throughout the catalytic cycle by adding ligands, which suggests that there was little
difference in the fraction of MBP bound with the transporter throughout the catalytic
cycle. No change in the immobility was detected from the spectra upon the addition of
maltose. This implies that maltose does not change the binding or conformation at the
interface of P2 and MBP N-lobe. In addition, a slight increase in the immobility shoulder
was observed upon the addition of ATP and EDTA, suggesting a more stable binding of
P2 and MBP at the ATP-bound transition state (6). Addition of Mg2+ ion and ATP
promoted ATP hydrolysis by MalFGK2, followed by a return of the MBP E274C
spectrum to overlap with that of maltose-bound MBP and MalFGK2 alone.

3.3

Initial interaction between MBP N-lobe and MalG

To investigate the initial interaction between MBP N-lobe and MalG, site 41 of
MBP was mutated into cysteine and labeled for EPR. The MacConkey assay showed that
the MBP D41C mutant supports maltose transport in the presence of the maltose
transporter. Then the spin-labeled MBP D41C was concentrated to 60 μM for EPR
experiments with MalFGK2 in detergent and reconstituted in nanodiscs and the results
were consistent.
The increase of viscosity by FicoII in the sample of MBP 41C and maltose did not
cause any change in the shoulder of the spectrum (Figure 3.2B). This implies that any
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change in the spectrum shoulder is caused by the more immobile environment of the
backbone near the spin label site.
Upon the addition of MalFGK2, the shoulder in the spectrum of MBP41C +
maltose increased. When the spectrum of the MBP D41C mutant with maltose and
MalFGK2 was compared with the spectrum of the MBP D41C mutant with maltose alone
(Figure 3.2B), it was clear that addition of MalFGK2 resulted in a two-component
spectrum. The more mobile component appeared to correspond to the unbound MBP,
whereas the less mobile component (indicated with an arrow) corresponded to MBP
bound to MalFGK2 at the interface of MalG and MBP. It was estimated that 89% of the
MBP was bound to MalG based on the subtraction of the unbound MBP from the
composite spectrum. Addition of Vanadate Mg-ATP to mimic the transition state causes
the percent bound MBP to increase to about 96% (6). The EPR spectra of MBP D41C
and MalFGK2 in nanodiscs in the presence or absence of maltose were compared (Figure
3.2C). A decrease in the mobility was observed upon the addition of maltose, indicating
that substrate binding of MBP promotes the docking of MBP N-lobe onto MalG.
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(A)

(C)

Figure 3.3 Interaction of MTSL-modified MBP D41C with MalFGK2. (A) Location of
MBP D41 in the maltose transporter (PBD ID: 3PV0). Colour codes: magenta, MBP;
yellow, MalF; cyan, MalG; red and green, MalK dimer. MBP D41 is shown in an
enlarged view in darker magenta. (B) The interaction of MBP41C with MalFGK2 and the
effect of maltose ligands. The small picture on the right shows the effect of Ficoll. MBP
E41C was present at 50 μM and 100 μM MalFGK2 was stabilized in 0.01% DDM. (C)
The effect of maltose on 50 μM MBP41C and 100 μM MalFGK2 stabilized in nanodiscs.
The buffer in (B) and (C) contains no NaCl. EPR spectra are 100G wide and are overlaid
with colors that are coded according to the ligands added. EPR spectra in (B) are
normalized to the same number of spins while spectra in (C) are normalized to the
maximum amplitude.

In agreement with literature, the signal of the immobile component increased
upon the addition of the transporter to MBP D41C (Figure 3.2B), indicating that MBP
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docks onto the transporter and changed the mobility at site 41 (43). However, the percent
of MBP bound in Figure 3.2B is higher than that reported in the literature (about 89%
versus 60%). A viable explanation for this discrepancy is the different concentrations of
MBP and the transporter used.
In contrast to the decrease in mobility upon addition of maltose in Figure 3.2C,
previous literature showed that no significant change in the mobility at position 41 upon
the addition of maltose to MBP41C and MalFGK2 (43). The possible explanation is that
NaCl concentration is different. The buffer in this study contained no NaCl whereas the
buffer in previous studies contained 150mM NaCl. The higher concentration of NaCl
likely weakened the electrostatic interaction between MBP and the transporter to such an
an extent that the interaction signal was not detected.

3.4

Initial interaction between MBP C-lobe and MalF

In the previous two sections, initial interaction between two regions of MBP N-lobe
and MalFG were reported. This section reports on the interaction between MBP C-lobe
and MalF. The EPR experiments on MBP C-lobe was majorly performed by Dr. Frances
J.D. Alvarez (45). I helped her do some of the experiments.
The spectra of MBP 345C changed similarly slightly upon the addition of
transporter as upon the addition of 20% Ficoll. In addition, no obvious difference was
observed upon the addition of maltose. These suggested that the majority of MBP C-lobe
does not dock onto the maltose transporter without nucleotide. Different from our EPR
results, the C-lobe of MBP in the pre-translocation structure crystallized is on the maltose
transporter.
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A rational explanation for this difference is that MBP is in equilibrium between
association and dissociation with the maltose transporter and crystal structure can only
represent the one conformation that favors crystal packing. In contrast, EPR is able to
represent real equilibrium in its natural environment. These can be supported by the fact
that the pre-translocation complex cannot be co-purified by gel purification, probably
because of weak binding between MBP and the maltose transporter in the presence of
maltose alone. This suggests that the pre-translocation crystal structure is not the most
stable conformation in solution.

Figure 3.4 Interaction of MTSL-modified MBP 345C with MalFGK2. Left, the
interaction of MBP 345C with MalFGK2. Right, the effect of Ficoll on the ERP spectra of
MBP 345C. The EPR spectra are 100G wide and are overlaid. EPR spectra in are
normalized to the same number of spins. MBP was present at 60 µM and MalFGK2 at
120 µM. Ligands were added at the concentrations specified in chapter 2. All
experiments with MalFGK2 present were performed in detergent (DDM) solution. The
spectra recorded without (black) or with (grey) maltose are overlaid.
3.5

Discussion

Previous studies reported the importance of periplasmic regions in MBPstimulated maltose transport by showing that three mutations on these loops partially
restore transport of a maltose-negative mutant (MalK Q140K) that was impaired in MBPstimulated ATPase activity (28). Among these periplasmic loops, P2 is unique to
Enterobacteriaceae maltose transporter (46). In agreement with previous NMR and
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crosslinking studies (24, 47), we found that P2 is in close contact with MBP N-lobe
throughout the catalytic cycle (Figure 3.1B), suggesting P2 is important in recruiting of
MBP.
Maltose induces a more immobile interaction between MalG and MBP at site
41(Figure 3.2C). P3, a loop of MalG, is one periplasmic loop at the interface of MBP Nlobe and MalG, which was demonstrated to be important in substrate translocation from
MBP to MalFG by “scooping” maltose out of the MBP maltose binding site and blocking
the rebinding of maltose to MBP (48). The increase of immobility at the interface of P3
and MBP might result from a conformational change of P3 upon the addition of maltose
and thus we suspect that MalG-P3 might be sensitive to substrate binding. In addition, in
agreement with the vanadate trapping studies (26), the increase in immobility at both site
274 and 41 suggests a more stable binding of MBP and MalFGK2 at transition state
(Figure 3.1B and Figure 3.2B).
In summary, three regions of MBP were spin-labeled and the spin label mobility
was studied. MBP N-lobe interacts with MalF-P2 throughout the transport cycle; mobility
decreases upon the addition of maltose at the spin label site of 41 suggesting stronger
interaction between MBP N-lobe and MalG; mobility did not change significantly at the
spin label site 345 indicating no significant change in interaction between MBP C-lobe
and MalF. These suggest that maltose enhances initial interaction between MBP and the
transporter by promoting N-lobe interaction, which explains why maltose-bound MBP
stimulates transporter more efficiently than maltose-free MBP. Although P2 maintains a
close contact with MBP N-lobe throughout the catalytic cycle, the exact role of P2 is
unclear. In the next chapter, we investigated the functional effect of P2 truncation.
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CHAPTER 4. FUNCTIONAL STUDY OF MALF-P2

4.1

Introduction

In literature, it was reported that isolated P2 can fold independently of the
transporter complex and the P2-MBP dissociation constant determined by isothermal
titration calorimetry experiments is on the order of 10-20 μM, similarly in the presence or
absence of maltose (47). Since the binding affinity of the intact maltose transporter is also
in the micromolar range, the authors proposed that P2 is sufficient to bind MBP (47).
Recently, further investigation was reported on the effect of isolated P2 on MBP (49). A
third conformation is adopted by the maltose-bound MBP in the presence of P2 that is
distinct from the closed maltose-bound MBP and open maltose-free MBP (49). Increased
solvation rates for residues in the substrate-binding pocket were observed upon the
addition of P2 by solvent-PRE measurements, further indicating a change in the solvent
accessibility of the maltose-binding cleft in the presence of P2 (49). These data indicate
that a possible third conformation of MBP induced by P2 could be a semi-open
conformation which might play an important role in the activation of substrate transport
by stabilizing the complex during the catalytic cycle. However, due to the lack of other
contact interfaces between MBP and MalFG, the interaction between the isolated P2 and
MBP may not work the same way as when it is part of the intact maltose transporter.
Besides, the periplasmic loops among other bacterial maltose ABC transporters are much
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shorter and are missing in homologous systems from Gram positive bacteria and archaea,
where MBP is tethered to the membrane. Therefore, it is likely that P2 in the actual
complex of maltose transporter in E. coli may function differently from the study of
isolated P2. The EPR studies in Chapter 3 have demonstrated that P2 is important in
recruiting MBP and MBP movement. To test whether P2 has additional important
functions, a truncation that replaces P2 with a short GSGSG linker was constructed in
both the wild-type maltose transporter and one BPI maltose transporter to carry out in
vivo and in vitro assays. The linker is for the purpose of maintaining the natural structure
of the maltose transporter after deleting P2 by linking the two segments of MalF.
4.2

Effect of P2 truncation on Maltose Transport In Vivo

Maltose transport of the P2-deleted maltose transporter mutant MalF(ΔP2)GK2
(section 2.1) was tested by in vivo MacConkey assay. We showed that the mutant exhibits
an in vivo transport negative phenotype on maltose MacConkey agar (Table 4.1). This
indicated that deletion of P2 prevents maltose transport in E. coli. This agrees with
previous report on the maltose uptake deficient phenotype of four MalF-P2 mutants (46),
which indicated that P2 is necessary for maltose transport conducted by the E. coli
maltose transporter system. According to the literature, the binding affinity between the
isolated MalF-P2 and MBP (about 10-20 μM) is similar to the Km of the MBP-stimulated
ATPase of the wild-type maltose transporter, MalFGK2 (27, 47). The significance of P2
in recruiting MBP is also supported by the EPR results of MBP E274C (Chapter 3). Thus
a rational explanation for the dysfunction of MalF(ΔP2)GK2 is that the binding affinity
drops too low for MalF(ΔP2)GK2 to bind MBP. The following sections describe how
MalF(ΔP2)GK2 was purified and characterized in vitro, and then tested whether the
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substrate-stimulated ATPase can be compensated by increasing MBP concentration to
1mM 。

Table 4.1 Characterization of E. coli maltose transporter mutants.
Strain AD126
MacConkey
with Complex Variant

Colony Color*

MalF(ΔP2)GK2+MBP

White

MalF(ΔP2)GK2, no MBP

White

MalFGK2 (wild type)+MBP

Red

MalFGK2 (wild type), no MBP White
MalF500GK2, no MBP

Red

MalF500 (ΔP2) GK2, no MBP

Red

*

Maltose-fermenting E. coli appears as red colonies on a MacConkey Agar with 1%
maltose, indicating a successful maltose transport into the cell. The observation was made
after 14-hour incubation at 37 The color of the colonies of each sample is uniformly
red or white. Observation after 12-hour incubation of MalF500 (ΔP2) GK2, no MBP
shows smaller red in the middle of the colony with white edges, indicating a slower
maltose metabolic rate.

It is known that binding-protein independent (BPI) proteins are able to couple
substrate transport and ATP hydrolysis in the absence of the periplasmic substrate
binding protein. To verify whether deletion of P2 disrupts the catalytic cycle, a binding
protein independent (BPI) mutant was introduced to the P2 truncation mutant of the
maltose transporter and the name of this mutant is F500ΔP2GK2. Briefly, the mutations
in MalF or MalG permits binding protein independent transport of maltose (31). Recall
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that BPI can transport maltose without MBP. A rational explanation of this is that the
majority of BPI rests in a high energy intermediate conformation.
BPI is expected to maintain maltose transport function even in the absence of P2.
F500 contains two site-mutations (G338R and N505I). The gene of malF500 with the P2
deleted, denoted malF500 (ΔP2) was constructed by mutagenesis. In the absence of MBP,
F500 (ΔP2) exhibited an in vivo Mal+ phenotype on maltose MacConkey agar after 14hour incubation (Table 1). This showed that the binding-protein independent mutant,
F500 can transport maltose without P2. In addition, comparing column 2 and 3 in Table
4.2, it took longer for the F500 (ΔP2) colonies to completely turn red than the F500
colonies. This indicates that the maltose transport of F500 is possibly slowed down by the
deletion of P2 with the assumption that the expression level of F500 and F500 (ΔP2) are
comparable. This assumption is based on similar numbers of colonies grown on the
medium under the same conditions.
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(A)

(B)

Figure 4.1 Maltose transporters visualized by 15% SDS-PAGE gels and Commassie
staining. The (A) F500. Lane 1, F500. Lane 2, wild-type MalFGK2. Lane 3, Molecular
weight markers. (B) Fractions from steps of purification of F500 ΔP2 from the membrane.
Lane 1, total membrane. Lane 2, Solubilized membrane. Lane 3, Cobalt unbound. Lane 4,
2 mM imidazole wash of cobalt resin. Lane 5, 5 mM imidazole wash of cobalt resin.
Lane 6, 100 mM imidazole elution of cobalt resin. Lane 7, MalF(ΔP2)GK2. Lane 8,
Molecular weight markers.

To further verify the role of P2 using the BPI mutant in vitro, different buffers
were used to purify F500 and F500 ΔP2 GK2. F500 was successfully purified with the
protocol described previously in section 2.2.1. However, the pure form of F500 ΔP2 GK2
could not be obtained (Figure 4.6). The band at the position of MalG is missing for the
elution of F500(ΔP2) from cobalt resin, although there are bands at the right positions
indicative of the presence of MalK and MalF500ΔP2. There are four possible reasons for
a failure of membrane protein purification: (1) gene mutation due to some reasons like
cell toxicity, (2) low expression level, (3) mislocation to the inclusion body, and (4) misfolding or aggregation. The first possibility, unexpected gene mutation, can be ruled out
since the gene sequences of malF500ΔP2 and malG were double checked after 24-hour

35
induction with 50 μM IPTG at 22

. A more rational explanation is that either the

expression level is too low or the mutant is misfolded.

4.3

Purification of MalF(ΔP2)GK2

The protein purification protocol in Section 2.2 was modified to obtain stable and
pure MalF(ΔP2)GK2 mutant in vitro. High purity was achieved by using DDM in a buffer
containing 50 mM Tris-HCl and 100 mM NaCl, at pH7. Purified MalF(ΔP2)GK2 was
first characterized on the 15% SDS-PAGE gel (Figure 4.1A). Three bands (lane 1)
corresponding to three components of MalF(ΔP2)GK2 were observed at the right position
with a reference of the positions of the three bands of wild-type MalFGK2 (lane 3). A
sharp

symmetrical

profile

of

purified

MalF(ΔP2)GK2

in

the

size-exclusion

chromatography analysis (Figure 4.1B) suggested that MalF(ΔP2)GK2 is reconstituted as
a complex and is well folded. To test whether the dysfunction of MalF(ΔP2)GK2 is due to
lack of interaction with MBP, MalF(ΔP2)GK2 was stabilized in nanodiscs with optimized
lipid:Membrane Scaffold Protein (MSP):MalFGK2 ratio to mimic the membrane
environment (section 4.4) and then ATP ase activity was measured with up to 1mM MBP
(section 4.5).
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Figure 4.2 Purification of MalF(ΔP2)GK2. (A) MalF(ΔP2)GK2 visualized by 15% SDSPAGE. Lane 1, MalF(ΔP2)GK2. Lane 2, an example of an attempted purification of
MalF(ΔP2)GK2 under a different condition but showed only one band. Lane 3, MalFGK2.
Lane 4, Molecular weight markers. (B) The elution profile of the gel filtration column.
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4.4

Functional Reconstitution of Nanodiscs

As outlined in Chapter 2, the nanodisc assembly mixture consists of the DDMpurified transporter, detergent solubilized soybean phospholipids and MSP. Previous
literature indicated that one transporter per nanodiscs is better than two per nanodiscs
because the former one displays higher ATPase activity, and that the MSP:MalFGK2
ratio needs to be above 5:1 (w/w) to make the major fraction be one transporter per
nanodiscs (39). To optimize the ATPase activity, the lipid:MSP:MalFGK2 ratios were
varied to reconstitute the nanodiscs assembly and then characterized with size-exclusion
chromatography, analytical ultracentrifugation as well as ATPase activity assay.
Nanodiscs were prepared with 50:1 (w/w) lipid to MSP and with MSP to MalFGK2
varying from 20:1 to 5:1 (w/w). The crude assembly was analyzed with size-exclusion
chromatography (Figure 4.2 D-F). With reference to the elution volumes of standard
proteins with known molecular weight described in section 2.5, the component that
contains one transporter per nanodisc appears to be the major symmetric peak eluted
around 1.4 mL in the size-exclusion chromatography profile (Figure 4.2). The shoulders
between 1.0~1.1 mL and around 1.6 mL are larger-size aggregation and smaller-size
impurities, respectively. At either 10:1 or 20:1, the aggregation is minimal. As the
MSP:MalFGK2 ratio increases, the smaller-size impurities increases. A rational
interpretation was that as the ratio of MSP: MalFGK2 increases, the amount of empty
nanodiscs with only MSP and lipid increases. Following affinity purification (Figure 4.2
(A) - (C)) the peaks are more symmetric but the yields are much lower than the crude
samples. In sum, 10:1 MSP to MalFGK2 can minimize the number of aggregation and

38
empty nanodiscs. To maintain yield and save proteins, we prefer to use the crude
assembly instead of purifying the nanodiscs with affinity chromatography.

45
40
35
A
B
C
D
E
F

mAU

30
25
20
15
10
5
0
0

0.5

1

ml

1.5

2

2.5

Figure 4.3 Nanodiscs size-exclusion profile with different MSP:MalFGK2 ratios. (A)
MSP:MalFGK2=5, nanodiscs were purified with Ni affinity column; (B)
MSP:MalFGK2=10, nanodiscs were purified with Ni affinity column; (C)
MSP:MalFGK2=20, nanodiscs were purified with Ni affinity column; (D)
MSP:MalFGK2= 5, nanodiscs were the crude assembly that were not purified with Ni
affinity column; (E) MSP:MalFGK2=10, nanodiscs were the crude assembly; (F)
MSP:MalFGK2= 20, nanodiscs were the crude assembly. MalFGK2 concentration was
approximately 6 μM. The lipid:MSP ratio was 50:1.

Previous literature showed that the ATPase activities of the nanodiscs varied less
than 40% in the 50:1 to 120:1 (w/w) lipid:MSP range (39). In this study, a broader range
of lipid:MSP ratio was investigated, from 500 to 5, corresponding to 2500 to 25
lipid:MalFGK2. The functional reconstitution was evaluated by ATPase activity (Figure
4.3). Both the lipid:MalFGK2 ratios of 250:1 and 500:1 showed high MBP-stimulated
ATPase activity. Moreover, their low ATPase activity in the absence of maltose or MBP
indicated that the complexes are well reconstituted.
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Figure 4.4 ATPase activity of nanodiscs with different lipid:MalFGK2 ratios. Top,
ATPase activity in the presence (black) or absence (red) of 5 μM MBP; bottom, ATPase
activity in the presence (black) or absence (red) of 100 μM maltose. 6 μM MalFGK2 were
used in the assay. MSP: MalFGK2 equaled to 5 for the samples in the presence of MSP.
The number labeled at the bottom of each column indicates the ratio of lipid: MalFGK2.
The label “MalFGK2” at the bottom of the columns means that MalFGK2 was stabilized
in 0.01% DDM without lipid or MSP.
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To verify that the dominant component of the nanodiscs reconstituted are in the
form of one transporter per two MSP, the major peak fraction of the nanodiscs in the
size-exclusion chromatography profile was collected and concentrated to approximately 6
uM. The samples were analyzed by our collaborator Dr. Paul Lake with analytical
ultracentrifugation. The ratio of lipid: MalFGK2:MSP was fine-tuned according to the
AUC profile of impurities and desired product intensity, among which the ratio of
lipid:MSP:MalFGK2 = 500:10:1 displayed the cleanest profile with two sharp major
peaks (Figure 4.4). The two major peaks in the AUC profile corresponded to
sedimentation coefficient 3.3 S and 9.4 S, respectively. The molecular weights of the two
components are estimated to be 41 kDa and 204 kDa, respectively. Thus the left peak in
Figure 4.4 represents MBP (43 kDa). The most likely interpretation of the right peak is
the nanodiscs with one transporter (171 kDa) per two MSP (28 kDa). The molecular
weight estimated from the sedimentration coefficient would be too small to represent two
transporters per two MSP. No obvious higher order aggregates or smaller-size impurities
were shown, indicating a successful optimization of the protocol to reconstitute one
transporter with two MSP.
This section showed that lipid:MSP ratio falling in between 50-100:1 and
MSP:maltose transporter ratio ranging from 5:1 to 10:1 are able to maximize the
component of nanodiscs containing one transporter per two MSP and to maintain high
level of MBP stimulated ATPase activity. Based on these results, lipid:MSP:maltose
transporter = 100:5:1 was chosen to test whether increasing concentration of MBP up to
1mM.

41

MBP
3.3 S

Nanodis
9.4 S
c

Figure 4.5 AUC profile of MalFGK2 nanodiscs with and without maltose.
4.5

ATPase Activity of MalF(ΔP2)GK2 in Nanodiscs

From the previous two sections, the pure protein of MalF(ΔP2)GK2 was obtained in
vitro and the functional nanodiscs reconstitution protocol with wild-type MalFGK2 was
optimized. The binding affinity of MalF(ΔP2)GK2 and MBP is too low to be measured
directly. To verify that the dysfunction of the transporter by the truncation of P2 was due
to the decrease of binding affinity with MBP, MalF(ΔP2)GK2 was reconstituted into
nanodiscs and ATPase activity with a gradient of high concentrations of MBP was
performed.
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Figure 4.6 ATPase activity assay of MBPMalF(ΔP2)GK2. (A) Binding curve of
MBP with maltose showing the
dissociation constant of MBP with
maltose to be 2.1 ±0.2 μM. (B) The ability
of MBP to stimulate the wild-type
MalFGK2 ATPase, at MBP concentrations
from 0 to 30 μM was measured in the
presence of 150 μM maltose at
. The
datapoints were fitted with the MichaelisMenten equation. (C) The ATPase activity
of the wild-type maltose transporter
stabilized in nanodiscs was measured in
the presence of 150 μM maltose and in the
absence or presence of 10 μM MBP at
22
and the ATPase activities were
shown in columns. (D) The ATPase
acitivity of the MalF(ΔP2)GK2 stabilized
in nanodiscs with a gradient amount of
MBP ranging from 0 to 1 mM were
measured in triplicates
. The assay
was conducted in the presence of 150 μM
maltose. Both the wild-type transporter
and MalF(ΔP2)GK2 are reconstituted in
nanodiscs.
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If recruiting MBP to the transporter is the sole role of P2, MBP-stimulation of
ATPase should have displayed a Michaelis-Menten curve, the slope of which increased
as the concentration MBP increased before saturation. The ATPase activity of
MalF(ΔP2)GK2 stabilized in nanodiscs with MBP ranging from 100 μM to 1 mM was
measured in the presence of 150 μM maltose and 1.5 mM ATP at 22

(Figure 4.5D).

The solubility of MBP in water is estimated to be about 5 mM. In addition, MBP
increases the viscosity of the solution, thus making it hard to add high concentrations of
MBP and mix the reagents in the solution. A MBP concentration of 1 mM is
approximately the upper limit that can be used in the ATPase activity assay.
The ATPase activity of MalF(ΔP2)GK2 in the presence of 1 mM MBP (57.7
nmol/mg/min) is less than 10% higher than that in the absence of MBP (52.7
nmol/mg/min) (Figure 4.5D). If this is explained by the fact that the Km for
MalF(ΔP2)GK2 is much higher than 1094 μM, the ATPase activity should still increase
as the concentration of MBP increases from 0 to 1 mM, since the amount of MBP bound
to the transporter increases as the amount of MBP increases before saturation. However,
instead of a positive correlation between the ATPase activity and the concentration of
MBP before saturation, the curve of the ATPase activity of MalF(ΔP2)GK2 versus MBP
concentration was flat. This indicated that the function of maltose transport is disabled by
the deletion of P2. Regardless of no increase in the ATPase activity, MalF(ΔP2)GK2 still
displays an absolute value of 50 ~ 60 nmol/min/mg ATPase activity, suggesting that
MalK dimer is still an active ATPase after truncation of P2.
As a control of MBP stimulation, the ability of MBP to stimulate the wild-type
MalFGK2 ATPase stabilized in the form of proteoliposome at MBP concentrations from
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2.5 to 27 μM was measured in the presence of 150 μM maltose and 1.5 mM ATP at 37
(Figure 4.5B). The curve fits to the Michaelis-Menten equation which yielded Km value
of approximately 7 uM, consistent with the reported Km value of about 15 uM (27). The
nanodiscs reconstitution and the assay conditions were controlled by the wild-type
maltose transporter nanodiscs. The ATPase activity of MalFGK2 was 1949.1
nmol/mg/min in the presence of 10 μM MBP and 43.7 nmol/min/mg in the absence of
MBP(Figure 4.5B), displaying a MBP-stimulation of about 45-fold, consistent with the
literature (27). In addition, the background reading from MBP and the reagents for the
ATPase activity assay was negligible.
To verify that the maltose concentration in the ATPase assay is abundant for MBP,
the dissociation constant (Kd) of MBP with Maltose was determined by intrinsic
fluorescence (Figure 4.5A) to be 2.11±0.22 μ M. This is consistent with the reported Kd
(3 μ M) (48, 50). Thus, 150 μM maltose in the ATPase activity assay is abundant for
MBP.
In summary, P2 loop deletion disrupted the MBP stimulation of ATPase activity of
the maltose transporter complex, and it cannot be rescued by increasing maltose-MBP
concentration up to 1mM.

4.6

Discussion

To test functions of P2, a mutant which has a replacement of P2 with a short GSGSG
linker, MalF(ΔP2)GK2 was purified and characterized. Before testing ATPase activity
assay with MalF(ΔP2)GK2 in nanodiscs, we optimized the functional reconstitution of the
nanodiscs and physically characterized the components. Our result showed that
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MSP:MalFGK2 ratio should be 5:1 in order to minimize the amount of aggregation and
empty nanodiscs in the crude nanodiscs. Lipid: MalFGK2 should be 50~100:1 to maintain
a high MBP-stimulated ATPase activity of MalFGK2. The nanodiscs were demonstrated
to contain one MalFGK2 per two MSP by the sedimentation coefficient of the assembly.
In agreement with the ability of MalF(ΔP2)GK2 to be co-crystalized with EIIAGlc,
our results suggest that the MalF(ΔP2)GK2 is well-folded. However, the function of
MalFGK2 was disabled by the deletion of P2 (Table 4.1). Wild-type MalFGK2 reaches
the maximal ATPase activity with only 20-25 μM MBP. However, no MBP-stimulated
ATPase activity of MalF(ΔP2)GK2 was detected even in the presence of 1 mM MBP
(Figure 4.5). This may due to the increase in Km to such an extent that 1 mM MBP
cannot bind MalF(ΔP2)GK2. Nevetheless, this study indicated that MalFGK2 cannot
interact with MBP in the absence of P2. And it suggested a possible role of the
interaction between P2 and MBP in inducing or stabilizing a high-energy intermediate
conformation of the maltose transporter between resting state and transition state. To
further test which steps in maltose transport catalytic cycle the interaction of P2 and MBP
are responsible for, we constructed a P2-deleted mutant on F500.
Binding-protein independent proteins, however, do not need MBP to transport
maltose into the cell (section 1.5). A rational explanation for the independence of MBP
for our study is that the resting state of BPI is distablized and that the majority of the BPI
mutant rests in a high-energy intermediate that can easily proceed to the out-ward facing
transition state conformation without the assistance of MBP (19, 25, 36), Based on this
assumption, we hypothesized that F500 is able to transport maltose without P2, which
was verified by the in vivo MacConkey assay (Table 4.2). Consistently, the crosslink data
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from Dr. Shanshuang Chen revealed that the maltose transporter is able to function when
it is crosslinked with MBP whereas lowering the local concentration of MBP by breaking
the disulfide bond between MBP and the transporter with DTT reduced ATPase activity
(24). Together with our finding that the MBP-P2 interaction is maintained throughout the
catalytic cycle and that F500 can function after P2 truncation, it is likely that P2 is only
involved in recruiting MBP.
Recent NMR studies have shown that the binding of P2 induces a semi-open state of
MBP both in the presence and absence of maltose (49). Conflicting results are found in
the pre-T state crystal structure in which MBP is not semi-open (19). This discrepancy
may due to the lack of interactions between MBP and other extracytoplasmic loops of
MalFG when using an isolated P2. Nevertheless, the possibility that MBP-P2 interaction
contributes to the conformational change from the resting state to the transition state
cannot be completely ruled out.
To conclude, chapter 4 mainly reported that P2 truncation in wild-type results in
loss of function whereas P2 domain is not essential for BPI mutant F500. It is possible
that MBP-P2 interaction is significant in the conformational change from resting state to
a high-energy intermediate, although no communication between 1 mM MBP and MalK
might due to too low binding affinity of MalF(ΔP2)GK2 to bind with MBP.
The current maltose transport model was modified based on the results in the thesis
(Figure 4.7). MalF-P2 maintains close contact with MBP N-lobe throughout the cycle.
Upon the addition of maltose, interaction between MalG short loops and MBP N-lobe
becomes much stronger while interaction between MalF short loops and MBP C-lobe
remains very weak.
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Figure 4.7 A Model of the E.coli maltose transporter catalytic cycle. The interaction
between MBP and MalFG in the inward-facing conformation and in the intermediate
conformations between inward-facing and outward-facing conformations are modified
according to our results and the reported model (19). MBP N-lobe initially interacts with
MalF-P2 even in the absence of maltose. Maltose triggers MBP closure and enhance the
interaction between MBP N-lobe and MalG, while MBP C-lobe remains in equilibrium
between associating and dissociating with MalF.
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APPENDIX INHIBITION OF MALTOSE UPTAKE
A.1 Introduction
The maltose transporter from Streptococcus pneumonia is crucial to survival of the
organism in the human host. Therefore, inhibitors of maltose uptake could, in theory,
would prevent infection (51). Based on the crystal structure of MalEFGK2, which reveals
the mode of interaction between maltodextrins and the two maltose-binding sites in the
transporter, we propose that modifications at the non-reducing end of a maltodextrin
might allow binding to MBP but prevent binding to MalF in the membrane. A mutation
in the MalF binding site (G380D) that prevented maltose binding resulted in uncoupling
of ATP hydrolysis from maltose transport (48), and suggested that a similar modification
of the sugar substrate might result in the consumption of ATP while inhibiting
maltodextrin (nutrient) uptake, leading to the death of the bacteria. The St. pneumonia
maltose transporter is a member of the ATP-binding cassette superfamily, bearing
similarity to the E. coli maltose transporter. We plan to test our hypothesis in the better
characterized maltose system before working with S. pneumonia.
In collaboration with the group of Dr. Alexander Wei at Purdue University, we
designed and chemically synthesized a molecule, named gal-glu4. It consists of one
lactose unit and one maltotriose unit (Figure 1). The reducing end of this drug mimics
maltose and is supposed to bind with the maltose binding site of MBP (52). But unlike
the alpha connection at the non-reducing end of maltose that binds the binding site at
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MalFG, the non-reducing end of this drug has a beta connection that is expected to be
unable to bind MalFG. Our lab has found (data not published) that gal-glu4, like maltose,
can stimulate ATPase activity of the E. coli maltose transporter. We hypothesize that galglu4 binds MBP and stimulates but fails to be transported may preferentially be bound by
MBP and keep consuming ATP. If this is the case, the bacteria will be killed. A question
of interest is whether a non-transported sugar analogue will be more effective as an
inhibitor of maltose transport than one that is transported, such as maltotriose.
One method for testing our hypothesis is to determine whether lower
concentrations of gal-glu4 are able to compete effectively for binding. In vitro maltose
uptake assay was also conducted to evaluate maltose uptake inhibition by the drug.

Figure A.1 The Model of Maltose Uptake Inhibition with Gal-glu4.
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A.2 Methods
Preparation of proteoliposomes is needed to mimic the natural environment in
which the maltose transporter complex is stabilized in membrane and the uptake of
maltose is from outside to the inside of the lipid vesicle. Proteoliposomes are prepared
following the description in (33).
H3-Maltose Transport Assay. The ratio of lipid: MalFGK2 in the proteoliposome
was 100:1 (w/w). The protein concentration was determined to be about 0.80 mg/ml with
an Amido Black assay. 35mM ATP and 20mM MgCl2 were added to the suspension
buffer and the PLV was flash frozen with dry ice and slowly thawed in the ice-water bath
6 times and then sonicated 10s on/off for 3 times until it became transparent. For the
transport assay, I used 2 μM 200 μCi/L H3-maltose. 25ul of the sample was loaded at
each time point onto the filter which connected to a pump. The filters were rinsed, dried
and then the radioactivity associated with the filters was read by a Liquid Scintillation
Counter.

A.3 Results
Figure 2 shows the dissociation constant (Kd) of maltose is 2.11±0.22 μ M and the
Kd of gal-glu4 is 2.13±0.22 μ M (3 μ M, ref 21). Their binding affinities are very close.

56

Figure A.2 Binding Curve and Binding Affinity of MBP with gal-glu4 (left) and maltose
(right).
The result of the in Vitro Maltose Transport Assay with Proteoliposomes is shown
in Figure 3. Maltose uptake is saturated within 30s when MBP is 1 or 2 μ M while the
one of the 0.5 μ M MBP group continued to take up maltose for 70 seconds. The maltose
uptake saturation amount appears similar for 0.5 to 2 μ M MBP. The result indicates that
using lower amounts of MBP slows down the rate of maltose uptake while maintaining
the maximum amount of maltose that can be taken up. Therefore, 0.5uM MBP is used for
the uptake assays.
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Figure A.3 Maltose Uptake Assay with 0.5 (blue), 1 (red), and 2 (green) μM MBP, and
MalFGK2 reconstituted in proteoliposomes.
The initial maltose uptake rates of the maltose transporter reconstituted in
proteoliposomes are listed in Table 1. The initial uptake rates of the samples in the
presence of gal-glu4 are lower than those without gal-glu4. However, the error of the
duplicate uptake initial rates of maltose transporter in the presence of 2 μM maltose and 1
μM MBP is as large as about 10 fold (0.00898 versus 0.00097 nmol/mg/s). The assay was
attempted to be reproduced and the results are shown in Table 2. But the errors between
duplicates are still as large as 1.5 to 2 fold.
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Table A.1 H3-Maltose uptake assay initial rate in the presence of gal-glu4
Initial Rate

R2

2 μ M maltose, 0.5 μ M MBP

0.0162

0.9927

2 μ M maltose, 1 μ M MBP

0.0898

1

2 μ M maltose, 1 μ M MBP (Duplicate)

0.0097

0.7273

2 μ M maltose, 0.5 μ M MBP, 1 μ M gal-

0.0079

0.9983

0.0078

0.9708

glu4
2 μ M maltose, 1 μ M MBP, 2 μ M galglu4
The unit of initial rate in the table is nmol/mg/s. The R2 written as “1” was because only
two data points are plotted before saturation in 30s.

Table A.2 H3-Maltose uptake assay initial rate in the presence of gal-glu3, gal-glu4 or
maltotriose
Duplicate 1

Duplicate 2

Average

Initial Rate

R2

Initial Rate

R2

Initial Rate

2 μ M maltose

0.031

1

0.0117

1

0.0214

2 μ M maltose

0.0034

1

0.0046

0.9768

0.0040

0.0056

0.9071

0.0072

0.8593

0.0064

0.0036

0.8660

0.0067

0.9789

0.0052

0.0065

0.9788

ND

ND

0.0065

2 μ M maltotriose

0.0066

0.9582

ND

ND

0.0066

4 μ M maltotriose

0.0031

0.8373

ND

ND

0.0031

+ 1 μ M gal-glu4
2 μ M maltose
+ 2 μ M gal-glu4
2 μ M maltose
+ 4 μ M gal-glu4
2 μ M maltose
+ 20 μ M gal-glu3
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In this assay, 2uM 3H maltose and 1uM MBP are present in each sample. The unit of the
initial rate is nmol/mg/s. ND: not determined. The R2 written as “1” was because only
two data points are plotted before saturation in 30s.

A.4 Discussion
The reported Kd for maltotriose binding to MBP is 0.16 μM (42), much lower than
that of maltose. Our results are consistent with this low dissociation constant by showing
a bigger initial uptake rate in the presence of 2 μM maltotriose and 2 μM maltose than in
the presence of 2 μM maltose alone. More experiments will be needed to determine the
Ki for maltotriose.
In comparison of the row 2 and row 5 in Table 1, the maltose uptake initial rate in
the presence of only 1 μM gal-glu4 is 10 times lower than that without gal-glu4. We
would be excited if this result is reproducible. However, the errors between the duplicates
undermine firm conclusions about the inhibition effectiveness of gal-glu4. Unfortunately,
these drugs are unavailable to repeat these results.
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